Tackling depression in cancer patients can extend life

Apr 10, 2008

David Spiegel highlights a research article for Faculty of 1000 Medicine that supports aggressive treatment of depression in cancer patients to extend their life expectancy.

A study recommended by David Spiegel of Faculty of 1000 Medicine (www.f1000medicine.com), looks at the relationship between depression care management and survival rates in older patients. He identifies it as “an important and well-conducted study of the effects of treatment of depression on survival in a primary care setting.”

A leading authority on mind-body interactions and professor of psychiatry and behavioural sciences at Stanford University, Spiegel evaluates the research published in the Annals of Internal Medicine, stressing the finding that “Comorbid depression shortens survival time with cancer, and intervention with medication and psychotherapy can therefore extend survival among cancer patients.”

The better survival rates were not seen in patients with depression and cardiovascular disease, only in those with cancer. Spiegel notes that this “is surprising given the well-known link between depression and poor cardiovascular disease outcome”.

He concludes, “Vigorous diagnosis and treatment programs for comorbid depression in cancer patients should, based on this study, extend survival time.”

Source: BioMed Central

Explore further: Many patients with advanced form of larynx cancer not receiving recommended treatment

Related Stories

Pets and anesthesia

Mar 21, 2014

Have you been avoiding getting your pet regular dental care? You're not alone. Most pet owners understand that in animals—just as in people—good oral health is conducive to overall well-being, says Gillian Fraser, V00, ...

Premature aging seen as issue for AIDS survivors

Jun 11, 2011

(AP) -- Having survived the first and worst years of the AIDS epidemic, when he was losing three friends to the disease in a day and undergoing every primitive, toxic treatment that then existed, Peter Greene ...

Recommended for you

New drug for neuroblastoma shows promise in phase I study

17 hours ago

Researchers at Spectrum Health Helen DeVos Children's Hospital have completed the first clinical trial of a new treatment for children suffering from neuroblastoma. In a clinical trial led by Giselle Sholler, MD, pediatri ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.